DrugsData.org (was EcstasyData): Test Details : Result #1973

- All Test Results
- Test Details
- Advanced Search
- Overview
- How the project is funded

© Copyright 2001-2023 Erowid Center. DrugsData is a project of Erowid Center. All rights reserved.

By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center. Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems. This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.

Your javascript is turned off. To remove this message, turn on javascript and accept the Terms of Use.

Donations are Matched in September!

Contribute $20 or more during our annual support-a-thon
and your donation will be DOUBLED.

Help us spread accurate info for harm reduction & benefit enhancement

Viewing desktop version: Switch to Mobile

Rolex

ID: 1973

ID:	1973
Name:	Rolex
Other Names:
HPLC:The HPLC Lab Test
mCPP : 44.70 mg mCPP aka 1-(m-chlorophenyl)piperazine, m-Chlorophenylpiperazine, m-CPP, 1-(3-chlorophenyl)piperazine Metoclopramide : 10.20 mg Metoclopramide aka Maxolon, Reglan, Degan, Maxeran, Primperan, Pylomid Domperidone : 2.50 mg Domperidone aka (Motilium, Motillium, Motinorm and Costi)

Test Date:	Apr 01, 2010
Pub. Date:	Aug 31, 2010
Src Location:	Zurich, Switzerland
Submitter Loc:	Zurich, -- Switzerland
Color:	Green / Speckled
Size:	292.3 mg, 8.10 x 4.90
Data Source:	Streetwork
Tested by:	DIZ
Lab's ID:

Note

This type of tablet was also tested in July 2010.

Send in a sample for testing

DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our DEA-licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.

Learn more

Support DrugsData

Should the public have access to independent analysis of the products they consume?

The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.

DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.

Donate now

Search Lab Results by	Advanced Search